Table 1.

Clinicopathologic characteristics for 14 patients receiving chemoradiation with panitumumab for LAPC

Patients, n
Characteristic(N = 14)%
Age (years at the start of the treatment)63 (46–77)
Sex
 Male1179
 Female321
Histology/cytology
 Adenocarcinoma1393
 Other: neuro-endocrine tumor17
Diagnosis based on
 Cytology4
 Histology10
T-stage
 T317
 T41393
N stage
 N014100
 N100
ECOG PS at start
 0964
 1536
Ca19,9 prior to therapy, U/mL
 Median103
 Range5–1,499